SCHEMBL10101788

SCHEMBL10101788

Cc1ccc(CO/N=C2\CCc3cc(C)c(O)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.36
MAOB P27338 3/20 0.36
MAPT P10636 6/20 0.34
ALDH1A1 P00352 3/20 0.34
ALOX15 P16050 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
G6PD P11413 1/20 0.34
CYP2C9 P11712 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
CCR6 P51684 1/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101787 0.93 MAOA (0.42) MAOAMAOBMAPTALDH1A1ALOX15
SCHEMBL10101786 0.89 MAOB (0.39) MAOAMAOBMAPTALDH1A1RAB9A
SCHEMBL10102259 0.85 MAPT (0.41) MAOAMAOBMAPTALDH1A1CYP1A2
SCHEMBL10101795 0.83 TUBB4A (0.30) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10102275 0.82 ALDH1A1 (0.36) MAPTALDH1A1ALOX15PKMMAPK1
SCHEMBL10101784 0.82 MAOA (0.45) MAOAMAOBMAPTALDH1A1HPGD
SCHEMBL10101834 0.80 MAOA (0.33) MAOAMAOBMAPTALDH1A1ALOX15
SCHEMBL10102248 0.79 MAPT (0.40) MAOAMAOBMAPTALDH1A1CYP1A2
SCHEMBL10101792 0.76 MAPT (0.34) MAPTALDH1A1RAB9AL3MBTL1GAA
SCHEMBL10102274 0.76 L3MBTL1 (0.40) MAPTALDH1A1ALOX15PKMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 MAOA 2304/4885MAOB 2633/4885MAPT 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.